Ризедронат Тева 35 мг

国家: 以色列

语言: 俄文

来源: Ministry of Health

现在购买

有效成分:

RISEDRONIC ACID AS SODIUM 35 MG

可用日期:

ABIC MARKETING LTD

ATC代码:

M05BA07

药物剂型:

TABLETS

给药途径:

PER OS

厂商:

TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY, HUNGARY

治疗组:

RISEDRONIC ACID

疗效迹象:

Treatment of postmenopausal osteoporosis to reduce the risk of vertebral fractures. Treatment of established postmenopausal osteoporosis to reduce the risk of hip fractures. Prevention of osteoporosis in postmenopausal women with increased risk of osteoporosis. Treatment of osteoporosis in men at high risk of fracture.

授权日期:

2011-10-01

其他语言的文件

资料单张 资料单张 英文 18-03-2018
资料单张 资料单张 阿拉伯文 18-03-2018
资料单张 资料单张 希伯来文 18-03-2018